AKT1 and Miyoshi myopathy: However, the upregulation of pim‐2 is independent of the PI3K/Akt pathway, suggesting that pim‐2 inhibitors, in combination with PI3K/Akt inhibitors, contribute to anti‐MM efficacy.30